ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

  • slider background

    Kidney Week

    The World's Premier Nephrology Meeting

Kidney Week 2023 Logo

The World's Premier Nephrology Meeting

Kidney Week 2023 Philadelphia, PA

Thank You! To All Participants

ASN thanks the approximately 12,300 participants of Kidney Week 2023 from across the globe for another successful meeting.

Post Meeting Resources

  • View 2,500+ ePosters through December 5, 2023.
  • Claim CME/CNE/CPE/MOC by December 20, 2023.
  • Download the Certificate of Attendance through February 3, 2024.
  • Access recorded content in the ASN eLearning Center for 3 years.

Save The Date!

Kidney Week 2024 will be held October 23-27, 2024 at the San Diego Convention Center in San Diego, CA.

Future Meeting Dates

Key Dates

October 31, 2023

Onsite Registration Opens in Philadelphia

November 1, 2023

Early Programs in Philadelphia

November 2-5, 2023

Annual Meeting

View All

Frequently Asked Questions

Learn more about the transition to a full digital meeting and get answers to common questions.

Technical Support

Need help navigating the virtual platform? Find technical support, an orientation video, and more.
#KidneyWk on X 1 day ago

Promising results of the VALIANT trial of pegcetacoplan for C3G/IC-MPGN were presented at #KidneyWk. #kidneydisease #nephrology https://t.co/X9KTTR...

View Post
#KidneyWk on X 2 days ago

RT @kidney_boy: Dietary potassium acts like a thiazide diuretic. Wow. That explains a lot. #KidneyWk https://t.co/FfiqYg9lSu

View Post
#KidneyWk on X 2 days ago

RT @rc_oncneph: A young trainee @ASNKidney #KidneyWk asks: what do onconephs do? IMO not always about identifying a novel renal toxicity…

View Post
#KidneyWk on X Friday, November 29 @ 4:30 AM

Final results of the IGNAZ study presented at #KidneyWk showed felzartamab led to sustained proteinuria reduction and reduced eGFR decline in IgAN....

View Post
#KidneyWk on X Friday, November 29 @ 1:56 AM

RT @VHIR_: 📌Un estudi internacional amb participació de @vallhebron mostra que el fàrmac semaglutida, per a l'obesitat i la diabetis, prote…

View Post
#KidneyWk on X Friday, November 29 @ 1:56 AM

RT @incliva_iis: 🗞️ Un estudio internacional en el que participa INCLIVA muestra que el fármaco Semaglutida, para la diabetes y la obesidad…

View Post
#KidneyWk on X Friday, November 29 @ 12:56 AM

RT @Medfyle1: Stay updated on IgA nephropathy with NEW expert podcast episodes from our ASN #KidneyWk Conference Coverage. Listen now: http…

View Post
#KidneyWk on X Friday, November 29 @ 12:56 AM

Stay updated on IgA nephropathy with NEW expert podcast episodes from our ASN #KidneyWk Conference Coverage. Listen now: https://t.co/OaE5DLCZkV #...

View Post
#KidneyWk on X Thursday, November 28 @ 11:15 AM

RT @brendonneuen: Identifying people with lower UACR who remain at high risk of CKD progression could facilitate more efficient & inclusiv…

View Post
#KidneyWk on X Thursday, November 28 @ 11:00 AM

RT @inozyme: Today, we presented positive interim data from our Phase 1 SEAPORT 1 trial of our lead program, INZ-701, in patients with end-…

View Post